01 Orion Corporation - Espoo (4)
02 Orion Corporation Orion Pharma (3)
03 Orion Corporation Orion Pharma, Espoo (1)
04 ABBVIE ENDOCRINE INC (2)
05 AbbVie (3)
06 AbbVie Inc (4)
07 ASTELLAS PHARMA SpA (3)
08 Astellas Pharma (NUF) (3)
09 Astellas Pharma AG (5)
10 GP Pharm, S.A (1)
11 GP-PHARM S.A. (1)
12 Labatec Pharma SA (2)
13 SANDOZ SpA (2)
14 Sandoz - Copenhagen (3)
15 Sandoz Pharmaceuticals AG (2)
16 TAKEDA ITALIA FARMACEUT.SpA (1)
17 TAKEDA ITALIA SpA (2)
01 LEUPROLIDE ACETATE (2)
02 Leuprolide Acetate (40)
01 Italy (9)
02 Norway (19)
03 Switzerland (12)
04 USA (2)
01 INJECTABLE;INJECTION (2)
02 Implant (3)
03 Injection (7)
04 Leuprorelin 11,25Mg 1 Unit Parenteral Use (1)
05 Leuprorelin 22.5Mg 1 Unit Parenteral Use (1)
06 Leuprorelin 3,6Mg Plant Parenteral Use (1)
07 Leuprorelin 3,75Mg 1 Unit Parenteral Use Rp - Intramuscular (1)
08 Leuprorelin 3,75Mg 1 Unit Parenteral Use Rp - Intramuscular And Subcutaneous Use (1)
09 Leuprorelin 45Mg 1 Unit Parenteral Use (1)
10 Leuprorelin 5Mg Plant Parenteral Use (1)
11 Leuprorelin 7,5Mg 1 Unit Parenteral Use (1)
12 Powder and liquid to depot injection fluid, suspension (1)
13 Powder and liquid to the injection fluid, resolution in the finished filled syringe (3)
14 Powder and liquid to the injection fluid, suspension (4)
15 Powder and liquid to the injection fluid, suspension in the finished filled syringe (4)
16 Powder and liquid to the injection fluid, suspension in two chamber syringe (4)
17 Solution (2)
18 Blank (4)